Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for MLTX

Stock Name	MoonLake Immunotherapeutics
Ticker	MLTX(USD) NASDAQ
TYPE	Common Stock
Country	USA

Show aggregate MLTX holdings

News associated with MLTX

Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) PT at $74.43: Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […] - 2025-09-22 02:42:53
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Rating of “Moderate Buy” from Brokerages: Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 […] - 2025-08-25 02:15:07
MoonLake Immunotherapeutics (NASDAQ:MLTX) Raised to “Hold” at Redburn Atlantic: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was upgraded by research analysts at Redburn Atlantic to a “hold” rating in a report issued on Monday,Zacks.com reports. Several other analysts also recently commented on the stock. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $67.00 price objective on shares of MoonLake Immunotherapeutics in […] - 2025-07-30 02:20:44
MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Up 2.7% – Still a Buy?: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) shares traded up 2.7% during trading on Wednesday . The stock traded as high as $48.02 and last traded at $47.86. 425,225 shares were traded during mid-day trading, an increase of 11% from the average session volume of 384,204 shares. The stock had previously closed at $46.61. Wall […] - 2025-07-03 04:28:52
The Math Shows ESML Can Go To $48: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-18 08:03:21
MoonLake Immunotherapeutics (NASDAQ:MLTX) Earns “Outperform” Rating from Royal Bank of Canada: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $67.00 price objective on the stock. Royal Bank of Canada’s target price points to a potential upside of […] - 2025-06-05 02:29:04
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 15:06:39
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 14:07:37
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 12:48:38
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 10:35:23
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 08:48:55
Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 20,141 MoonLake Immunotherapeutics (NASDAQ:MLTX): Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 20,141 shares of the company’s stock, valued at approximately $1,091,000. Several other hedge funds also recently added to or reduced their stakes in the stock. Deutsche Bank AG […] - 2025-06-04 05:24:49
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 03:47:05
Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-03 23:49:46
Stocks Climb as Chip Makers Rally and US Job Openings Increase: The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 18:26:24
Stocks Climb as Chip Makers Rally and US Job Openings Increase: The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 14:47:08
MoonLake Immunotherapeutics Breaks Above 200-Day Moving Average - Bullish for MLTX: In trading on Tuesday, shares of MoonLake Immunotherapeutics (Symbol: MLTX) crossed above their 200 day moving average of $45.66, changing hands as high as $49.48 per share. MoonLake Immunotherapeutics shares are currently trading up about 18.7% on the day. The chart below sho - 2025-06-03 14:16:02
Stocks Climb as Chip Makers Rally and US Job Openings Increase: The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 14:05:31
Stocks See Support as Bond Yields Slide: The S&P 500 Index ($SPX ) (SPY ) today is up +0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. June E-mini S&P futures (ESM25 ) are up +0.07%, and June E-mini Nasdaq futures... - 2025-06-03 12:50:06
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.: MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 13.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,456 shares of the company’s stock after purchasing an additional 1,866 shares during the period. […] - 2025-05-27 04:47:04
Nuveen Asset Management LLC Boosts Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX): Nuveen Asset Management LLC increased its stake in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 595,581 shares of the company’s stock after purchasing an additional 14,792 shares during the quarter. Nuveen Asset Management LLC […] - 2025-05-22 05:58:59
Wolfe Research Upgrades MoonLake Immunotherapeutics (NASDAQ:MLTX) to Outperform: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating in a report released on Monday, MarketBeat Ratings reports. The firm presently has a $61.00 price target on the stock. Wolfe Research’s price objective would indicate a potential upside of 51.44% from […] - 2025-05-21 02:42:44
Ameriprise Financial Inc. Boosts Stake in MoonLake Immunotherapeutics (NASDAQ:MLTX): Ameriprise Financial Inc. boosted its position in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 28.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 204,373 shares of the company’s stock after purchasing an additional 45,113 shares during the period. Ameriprise […] - 2025-05-19 04:30:54
Dimensional Fund Advisors LP Takes Position in MoonLake Immunotherapeutics (NASDAQ:MLTX): Dimensional Fund Advisors LP acquired a new stake in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm acquired 64,384 shares of the company’s stock, valued at approximately $3,485,000. A number of other institutional investors and hedge funds have also made changes to their positions in MLTX. PNC Financial […] - 2025-05-14 04:32:47
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $80.50 Consensus Price Target from Analysts: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. […] - 2025-04-25 02:52:47
MoonLake Immunotherapeutics (NASDAQ:MLTX) Sets New 12-Month Low – What’s Next?: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) hit a new 52-week low during trading on Monday . The stock traded as low as $34.13 and last traded at $35.04, with a volume of 339603 shares. The stock had previously closed at $37.21. Analyst Ratings Changes MLTX has been the topic of a number of recent […] - 2025-04-08 04:50:55
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $80.50 Average PT from Analysts: MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned an average rating of “Buy” from the eight brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. […] - 2025-03-31 02:46:59
MoonLake Immunotherapeutics (NASDAQ:MLTX) Now Covered by Royal Bank of Canada: Royal Bank of Canada assumed coverage on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a research report released on Tuesday, Marketbeat.com reports. The brokerage issued an outperform rating and a $67.00 price target on the stock. Several other analysts have also recently commented on the company. HC Wainwright reissued a “buy” rating and […] - 2025-03-19 05:12:49
ESGV's Underlying Holdings Imply 20% Gain Potential: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-10 09:44:02
Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) PT at $83.20: Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have earned a consensus recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-03-06 04:45:40

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc MLTX holdings

Date	Number of MLTX Shares Held	Base Market Value of MLTX Shares	Local Market Value of MLTX Shares	Change in MLTX Shares Held	Change in MLTX Base Value	Current Price per MLTX Share Held	Previous Price per MLTX Share Held
2025-09-26 (Friday)	22,135	USD 1,372,149	USD 1,372,149
2025-09-25 (Thursday)	22,135	USD 1,247,971	USD 1,247,971	0	USD 53,898	USD 56.38	USD 53.945
2025-09-24 (Wednesday)	22,135	USD 1,194,073	USD 1,194,073
2025-09-17 (Wednesday)	21,991	USD 1,125,499	USD 1,125,499	0	USD -45,742	USD 51.18	USD 53.26
2025-09-16 (Tuesday)	21,991	USD 1,171,241	USD 1,171,241
2025-09-12 (Friday)	21,847	USD 1,149,589	USD 1,149,589
2025-09-11 (Thursday)	21,847	USD 1,186,292	USD 1,186,292

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MLTX by Blackrock for IE00B3VWM098

Show aggregate share trades of MLTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -72 54.170* 44.40 Profit of 3,197 on sale
2025-07-31 BUY 216 50.440* 44.31
2025-06-30 SELL -144 47.200* 43.49 Profit of 6,263 on sale
2025-06-25 SELL -72 47.370* 43.41 Profit of 3,125 on sale
2025-06-20 SELL -144 43.500* 43.38 Profit of 6,247 on sale
2025-05-23 BUY 72 38.930* 43.39
2025-05-19 SELL -72 39.200* 43.53 Profit of 3,134 on sale
2025-05-15 SELL -216 37.660* 43.64 Profit of 9,425 on sale
2025-05-12 SELL -72 40.180* 43.77 Profit of 3,152 on sale
2025-05-09 SELL -72 38.470* 43.82 Profit of 3,155 on sale
2025-04-30 SELL -72 42.080* 44.04 Profit of 3,171 on sale
2025-04-24 SELL -144 39.450* 44.22 Profit of 6,368 on sale
2025-04-17 SELL -72 38.325* 44.49 Profit of 3,203 on sale
2025-04-15 SELL -216 36.770* 44.66 Profit of 9,646 on sale
2025-04-14 SELL -216 35.750* 44.75 Profit of 9,667 on sale
2025-04-09 SELL -288 35.980* 45.09 Profit of 12,985 on sale
2025-04-07 SELL -504 34.780* 45.35 Profit of 22,857 on sale
2025-04-04 SELL -720 37.210* 45.45 Profit of 32,721 on sale
2025-03-31 BUY 72 39.070* 45.73
2025-03-19 SELL -144 39.920* 46.36 Profit of 6,675 on sale
2025-03-14 SELL -432 38.550* 46.67 Profit of 20,161 on sale
2025-03-13 SELL -144 37.820* 46.80 Profit of 6,739 on sale
2025-03-12 SELL -2,448 39.310* 46.90 Profit of 114,821 on sale
2025-03-07 SELL -144 38.035* 47.33 Profit of 6,816 on sale
2025-03-06 SELL -216 39.820* 47.45 Profit of 10,249 on sale
2025-03-03 SELL -72 39.710* 47.81 Profit of 3,442 on sale
2025-02-28 SELL -432 41.760* 47.91 Profit of 20,696 on sale
2025-02-26 SELL -72 42.370* 48.10 Profit of 3,463 on sale
2025-02-25 SELL -216 40.730* 48.23 Profit of 10,418 on sale
2025-02-18 BUY 360 42.825* 48.82
2025-02-13 BUY 72 43.600* 49.15
2025-02-12 BUY 72 44.270* 49.25
2025-02-11 BUY 216 43.230* 49.37
2025-02-06 BUY 648 47.110* 49.63
2025-01-27 BUY 72 44.890* 50.54
2024-12-30 BUY 360 53.020* 50.63
2024-12-06 BUY 288 54.310* 50.33
2024-12-05 BUY 72 53.500* 50.22
2024-12-04 BUY 360 53.060* 50.12
2024-11-29 BUY 360 54.430* 49.69
2024-11-27 BUY 288 54.240* 49.29
2024-11-26 BUY 72 52.840* 49.13
2024-11-25 SELL -2,201 54.170* 48.89 Profit of 107,603 on sale
2024-11-21 BUY 393 51.860* 48.45
2024-11-20 BUY 234 49.820* 48.37
2024-11-18 BUY 936 48.540* 48.30
2024-11-12 BUY 624 51.890* 48.06
2024-11-08 BUY 390 51.780* 47.79
2024-11-07 BUY 1,170 50.670* 47.57
2024-11-06 BUY 156 51.480* 47.25
2024-10-31 BUY 78 46.420* 47.47
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-72	54.170*	44.40 Profit of 3,197 on sale
2025-07-31	BUY	216	50.440*	44.31
2025-06-30	SELL	-144	47.200*	43.49 Profit of 6,263 on sale
2025-06-25	SELL	-72	47.370*	43.41 Profit of 3,125 on sale
2025-06-20	SELL	-144	43.500*	43.38 Profit of 6,247 on sale
2025-05-23	BUY	72	38.930*	43.39
2025-05-19	SELL	-72	39.200*	43.53 Profit of 3,134 on sale
2025-05-15	SELL	-216	37.660*	43.64 Profit of 9,425 on sale
2025-05-12	SELL	-72	40.180*	43.77 Profit of 3,152 on sale
2025-05-09	SELL	-72	38.470*	43.82 Profit of 3,155 on sale
2025-04-30	SELL	-72	42.080*	44.04 Profit of 3,171 on sale
2025-04-24	SELL	-144	39.450*	44.22 Profit of 6,368 on sale
2025-04-17	SELL	-72	38.325*	44.49 Profit of 3,203 on sale
2025-04-15	SELL	-216	36.770*	44.66 Profit of 9,646 on sale
2025-04-14	SELL	-216	35.750*	44.75 Profit of 9,667 on sale
2025-04-09	SELL	-288	35.980*	45.09 Profit of 12,985 on sale
2025-04-07	SELL	-504	34.780*	45.35 Profit of 22,857 on sale
2025-04-04	SELL	-720	37.210*	45.45 Profit of 32,721 on sale
2025-03-31	BUY	72	39.070*	45.73
2025-03-19	SELL	-144	39.920*	46.36 Profit of 6,675 on sale
2025-03-14	SELL	-432	38.550*	46.67 Profit of 20,161 on sale
2025-03-13	SELL	-144	37.820*	46.80 Profit of 6,739 on sale
2025-03-12	SELL	-2,448	39.310*	46.90 Profit of 114,821 on sale
2025-03-07	SELL	-144	38.035*	47.33 Profit of 6,816 on sale
2025-03-06	SELL	-216	39.820*	47.45 Profit of 10,249 on sale
2025-03-03	SELL	-72	39.710*	47.81 Profit of 3,442 on sale
2025-02-28	SELL	-432	41.760*	47.91 Profit of 20,696 on sale
2025-02-26	SELL	-72	42.370*	48.10 Profit of 3,463 on sale
2025-02-25	SELL	-216	40.730*	48.23 Profit of 10,418 on sale
2025-02-18	BUY	360	42.825*	48.82
2025-02-13	BUY	72	43.600*	49.15
2025-02-12	BUY	72	44.270*	49.25
2025-02-11	BUY	216	43.230*	49.37
2025-02-06	BUY	648	47.110*	49.63
2025-01-27	BUY	72	44.890*	50.54
2024-12-30	BUY	360	53.020*	50.63
2024-12-06	BUY	288	54.310*	50.33
2024-12-05	BUY	72	53.500*	50.22
2024-12-04	BUY	360	53.060*	50.12
2024-11-29	BUY	360	54.430*	49.69
2024-11-27	BUY	288	54.240*	49.29
2024-11-26	BUY	72	52.840*	49.13
2024-11-25	SELL	-2,201	54.170*	48.89 Profit of 107,603 on sale
2024-11-21	BUY	393	51.860*	48.45
2024-11-20	BUY	234	49.820*	48.37
2024-11-18	BUY	936	48.540*	48.30
2024-11-12	BUY	624	51.890*	48.06
2024-11-08	BUY	390	51.780*	47.79
2024-11-07	BUY	1,170	50.670*	47.57
2024-11-06	BUY	156	51.480*	47.25
2024-10-31	BUY	78	46.420*	47.47

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MLTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	188,436	0	302,507	62.3%
2025-09-18	179,800	0	338,697	53.1%
2025-09-17	207,082	0	355,102	58.3%
2025-09-16	400,608	0	662,803	60.4%
2025-09-15	266,921	0	337,273	79.1%
2025-09-12	149,846	18	400,142	37.4%
2025-09-11	180,042	0	360,799	49.9%
2025-09-10	262,341	4,844	400,784	65.5%
2025-09-09	123,516	0	305,154	40.5%
2025-09-08	175,744	0	327,197	53.7%
2025-09-05	394,083	0	897,447	43.9%
2025-09-04	201,886	0	324,754	62.2%
2025-09-03	469,114	0	616,481	76.1%
2025-09-02	146,535	0	273,930	53.5%
2025-08-29	134,910	0	228,162	59.1%
2025-08-28	113,582	0	194,815	58.3%
2025-08-27	64,927	0	100,136	64.8%
2025-08-26	139,408	0	245,320	56.8%
2025-08-25	108,764	0	229,723	47.3%
2025-08-22	50,960	7	100,307	50.8%
2025-08-21	77,715	0	237,211	32.8%
2025-08-20	113,744	0	147,261	77.2%
2025-08-19	57,404	0	105,853	54.2%
2025-08-18	95,185	0	181,060	52.6%
2025-08-15	78,221	0	144,504	54.1%
2025-08-14	63,545	0	111,234	57.1%
2025-08-13	76,412	0	197,989	38.6%
2025-08-12	44,456	0	114,221	38.9%
2025-08-11	76,161	0	108,361	70.3%
2025-08-08	108,671	33,674	146,885	74.0%
2025-08-07	74,314	2,100	136,888	54.3%
2025-08-06	126,874	0	189,350	67.0%
2025-08-05	109,154	506	211,512	51.6%
2025-08-04	159,692	0	222,687	71.7%
2025-08-01	260,138	0	327,016	79.5%
2025-07-31	207,750	2,123	296,733	70.0%
2025-07-30	226,238	1,759	562,460	40.2%
2025-07-29	62,123	0	187,985	33.0%
2025-07-28	123,865	0	201,175	61.6%
2025-07-25	85,314	0	170,364	50.1%
2025-07-24	97,312	14	171,667	56.7%
2025-07-23	163,330	0	301,588	54.2%
2025-07-22	91,516	0	178,782	51.2%
2025-07-21	52,151	0	75,742	68.9%
2025-07-18	116,354	0	214,689	54.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE